Estradiol receptor antagonist reduces ventricular arrhythmia via L-type calcium channels in chronic heart failure

Minerva Cardioangiologica ◽

10.23736/s0026-4725.19.05100-4 ◽

2020 ◽

Vol 68 (1) ◽

Author(s):

Zhenlan Du ◽

Wenbo Xu ◽

Xiaoyan Chen ◽

Duo Xu ◽

Yingzi Li ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Ventricular Arrhythmia ◽

Calcium Channels ◽

Receptor Antagonist ◽

Estradiol Receptor

Download Full-text

Angiotensin II Receptor Antagonist Improves the Immune Activations of Patients With Chronic Heart Failure

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)83860-0 ◽

1998 ◽

Vol 31 (2) ◽

pp. 33A

Author(s):

T Tsutamoto

Keyword(s):

Heart Failure ◽

Angiotensin Ii ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist

Download Full-text

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease

European Journal of Heart Failure ◽

10.1002/ejhf.218 ◽

2015 ◽

Vol 17 (2) ◽

pp. 224-232 ◽

Author(s):

Bertram Pitt ◽

Stefan D. Anker ◽

Michael Böhm ◽

Mihai Gheorghiade ◽

Lars Køber ◽

...

Keyword(s):

Heart Failure ◽

Chronic Kidney Disease ◽

Chronic Heart Failure ◽

Kidney Disease ◽

Receptor Antagonist ◽

Mineralocorticoid Receptor ◽

Randomized Study ◽

Mineralocorticoid Receptor Antagonist

Download Full-text

GW25-e0796 Attenuation of CLOCK-BMAL1 transcriptionally decreases the expression of β1-AR to anticipate the occurrence of ventricular arrhythmia after chronic heart failure

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2014.06.349 ◽

2014 ◽

Vol 64 (16) ◽

pp. C75

Author(s):

Yuan Jiamin ◽

Zhiyong Qian ◽

Peibing Ge ◽

Yao Wang ◽

Yanhong Chen ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Ventricular Arrhythmia

Download Full-text

Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure

International Journal of Cardiology ◽

10.1016/j.ijcard.2011.12.080 ◽

2013 ◽

Vol 167 (1) ◽

pp. 244-249 ◽

Author(s):

Shu Kasama ◽

Takuji Toyama ◽

Hiroyuki Sumino ◽

Hisao Kumakura ◽

Yoshiaki Takayama ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Sympathetic Nerve ◽

Mineralocorticoid Receptor ◽

Sympathetic Nerve Activity ◽

Cardiac Sympathetic Nerve ◽

Nerve Activity ◽

Mineralocorticoid Receptor Antagonist ◽

Cardiac Sympathetic Nerve Activity

Download Full-text

Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252

Journal of Hypertension ◽

10.1097/00004872-200018100-00020 ◽

2000 ◽

Vol 18 (10) ◽

pp. 1507-1514 ◽

Author(s):

Johann Bauersachs ◽

Claude Braun ◽

Daniela Fraccarollo ◽

Julian Widdera ◽

Georg Ertl ◽

...

Keyword(s):

Myocardial Infarction ◽

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Renal Dysfunction ◽

Endothelin A Receptor ◽

Download Full-text

Safety and efficacy of an orally active selective endothelin—A receptor antagonist in moderate-severe human chronic heart failure

Journal of Cardiac Failure ◽

10.1016/s1071-9164(99)91521-x ◽

1999 ◽

Vol 5 (3) ◽

pp. 48

Author(s):

Horng H. Chen ◽

Lisa M. Salz ◽

Linda J. McKinley ◽

Lyle J. Olson ◽

Daniel D. Borgeson ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Safety And Efficacy ◽

Endothelin A Receptor ◽

Endothelin A ◽

Download Full-text

ASSA13-03-36 Effects of B3-Adrenergic Receptor Antagonist on Myocardial UCP2 Expression and Energy Metabolism in Chronic Heart Failure Rats

Heart ◽

10.1136/heartjnl-2013-303992.076 ◽

2013 ◽

Vol 99 (Suppl 1) ◽

pp. A25.2-A25

Author(s):

Kong Yi-hui ◽

Gao Yan-hui ◽

Di Ning-ning ◽

Li Wei-min

Keyword(s):

Heart Failure ◽

Energy Metabolism ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Adrenergic Receptor ◽

Ucp2 Expression

Download Full-text

The importance of a higher dose of a mineralocorticoid receptor antagonist in reducing risk of reccurent hospitalization in a patient with advanced chronic heart failure - A case report

Cor et Vasa ◽

10.1016/j.crvasa.2017.08.004 ◽

2018 ◽

Vol 60 (5) ◽

pp. e527-e530 ◽

Author(s):

Ghada Mairgani ◽

Václav Mála ◽

Filip Málek

Keyword(s):

Heart Failure ◽

Case Report ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Mineralocorticoid Receptor ◽

Mineralocorticoid Receptor Antagonist

Download Full-text

ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(15)60970-6 ◽

2015 ◽

Vol 65 (10) ◽

pp. A970

Author(s):

Parul U. Gandhi ◽

Shweta Motiwala ◽

Arianna Belcher ◽

Hanna Gaggin ◽

Rory Weiner ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Mineralocorticoid Receptor ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Mineralocorticoid Receptor Antagonist ◽

Download Full-text

A multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of dantrolene on ventricular arrhythmia as well as mortality and morbidity in patients with chronic heart failure (SHO-IN trial): rationale and design

Journal of Cardiology ◽

10.1016/j.jjcc.2019.08.020 ◽

2020 ◽

Vol 75 (4) ◽

pp. 454-461 ◽

Author(s):

Shigeki Kobayashi ◽

Takatoshi Wakeyama ◽

Shiro Ono ◽

Yasuhiro Ikeda ◽

Masato Omura ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Ventricular Arrhythmia ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Mortality And Morbidity

Download Full-text